Hamburg, Germany

Florian Repenn

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Kaden Biochemicals Gmbh, Symrise Ag. Active years: 2013.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Florian Repenn: Innovator in D-Galactose Extraction

Introduction

Florian Repenn is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of biochemistry, particularly in the extraction of D-galactose from vegetable materials. His innovative methods have the potential to impact various industries, including food and pharmaceuticals.

Latest Patents

Florian Repenn holds a patent for a "Method for extracting D-galactose from vegetable starting material by acid hydrolysis." This patent describes a systematic approach to extracting D-galactose, which is a sugar with various applications in food production and other sectors. His work in this area showcases his expertise and commitment to advancing biotechnological processes.

Career Highlights

Throughout his career, Florian has worked with prominent companies such as Symrise AG and Kaden Biochemicals GmbH. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects that enhance product development and efficiency.

Collaborations

Florian has collaborated with talented individuals in his field, including Nicolai Nagorny and Edgar Endlein. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

Florian Repenn is a distinguished inventor whose work in D-galactose extraction exemplifies innovation in biochemistry. His contributions to the industry are noteworthy, and his collaborations with other professionals further enhance his impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…